Methods of treating myotonic dystrophy type 1 using peptide-oligonucleotide conjugates
AssigneePepgen Corporation
InventorsCaroline GODFREY, Sonia BRACEGIRDLE, Ashling HOLLAND, Smita GUNNOO
Life of this patent
Estimating the term…
Loading patent…
AssigneePepgen Corporation
InventorsCaroline GODFREY, Sonia BRACEGIRDLE, Ashling HOLLAND, Smita GUNNOO
Estimating the term…
Disclosed are methods of treating a subject having myotonic dystrophy type 1 (DM1). The methods include administering a therapeutic regimen including a plurality of doses of a conjugate spaced at a time interval of at least 1 month, where the conjugate includes an oligonucleotide and a peptide covalently bonded or linked via a linker to the oligonucleotide, the peptide including a hydrophobic domain flanked by two cationic domains, each of the cationic domains including one of RBRRBRR (SEQ ID NO: 1), RBRBR (SEQ ID NO: 2), RBRR (SEQ ID NO: 3), RBRRBR (SEQ ID NO: 4), RRBRBR (SEQ ID NO: 5), RBRRB (SEQ ID NO: 6), BRBR (SEQ ID NO: 7), RBHBH (SEQ ID NO: 8), HBHBR (SEQ ID NO: 9), RBRHBHR (SEQ ID NO: 10), RBRBBHR (SEQ ID NO: 11), RBRRBH (SEQ ID NO: 12), HBRRBR (SEQ ID NO: 13), HBHBH (SEQ ID NO: 14), BHBH (SEQ ID NO: 15), BRBSB (SEQ ID NO: 16), BRB[Hyp]B (SEQ ID NO: 17), R[Hyp]H[Hyp]HB (SEQ ID NO: 18), and R[Hyp]RR[Hyp]R (SEQ ID NO: 19), and the hydrophobic domain including one of YQFLI (SEQ ID NO: 20), FQILY (SEQ ID NO: 21), ILFQY (SEQ ID NO: 22), FQIY (SEQ ID NO: 23), VWVW, WWPWW (SEQ ID NO: 24), WPWW (SEQ ID NO: 25), and VWVPW (SEQ ID NO: 26); and the oligonucleotide including a total of 12 to 40 contiguous nucleobases, where at least 9 contiguous nucleobases are complementary to a CUG repeat sequence.
A method of treating a subject having myotonic dystrophy type 1 (DM1), the method comprising administering a therapeutic regimen comprising a plurality of doses of a conjugate spaced at a time interval of at least 1 month, wherein the conjugate comprises an oligonucleotide and a peptide covalently bonded or linked via a linker to the oligonucleotide, the peptide comprising a hydrophobic domain flanked by two cationic domains, each of the cationic domains comprising one of RBRRBRR (SEQ ID NO:
The method of 62, wherein all morpholino internucleoside linkages in the morpholino are —P(O)(NMe2)O-.
Dependencies are inferred from the claim text.